Evidence map›Paper›PMID 28250416›Full record

ArticleNature structural & molecular biology2017

TOP2 synergizes with BAF chromatin remodeling for both resolution and formation of facultative heterochromatin.

Erik L Miller, Diana C Hargreaves, Cigall Kadoch, Chiung-Ying Chang, Joseph P Calarco, Courtney Hodges, Jason D Buenrostro, Kairong Cui, William J Greenleaf, Keji Zhao and 1 more

Open access · greenAbstract read
In one paragraph

Article in Nature structural & molecular biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 97 citations in OpenAlex.

  1. Article
  2. Article
  3. The Roles of Topoisomerases in Transcriptional Regulation.International journal of molecular sciences · 2026
    Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Highly sensitive mapping ofbioRxiv : the preprint server for biology · 2024
    Article
  17. Article
  18. Review
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Erik L MillerDepartment of Pathology, Stanford University School of Medicine, Stanford, California, USA.
Diana C HargreavesDepartment of Pathology, Stanford University School of Medicine, Stanford, California, USA.
Cigall KadochDepartment of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0002-4058-5985
Chiung-Ying ChangDepartment of Pathology, Stanford University School of Medicine, Stanford, California, USA.
Joseph P CalarcoDepartment of Pathology, Stanford University School of Medicine, Stanford, California, USA.
Courtney HodgesDepartment of Pathology, Stanford University School of Medicine, Stanford, California, USA.ORCID 0000-0003-4441-497X
Jason D BuenrostroBroad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
Kairong CuiSystems Biology Center, National Heart, Lung, and Blood Institute, US National Institutes of Health, Bethesda, Maryland, USA.
William J GreenleafDepartment of Genetics, Stanford University School of Medicine, Stanford, California, USA.
Keji ZhaoSystems Biology Center, National Heart, Lung, and Blood Institute, US National Institutes of Health, Bethesda, Maryland, USA.
Gerald R CrabtreeDepartment of Pathology, Stanford University School of Medicine, Stanford, California, USA.
Stanford University · USBroad Institute · USNational Institutes of Health · USHoward Hughes Medical Institute · US

Funding

Translational Oncology Research Program (Project-005)P30CA124435 · NCI · STANFORD UNIVERSITY · PI Melinda L. Telli · 2007 to 2026
$71.4M
INSTITUTIONAL TRAINING GRANT IN GENOME SCIENCET32HG000044 · NHGRI · STANFORD UNIVERSITY · PI MICHAEL P. SNYDER · 1995 to 2026
$32.2M
Genome-wide mapping of histone modificationsZIAHL005801 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI ZHAO, KEJI · 2009 to 2025
$24.0M
Epigenetic Regulation of Hematopoietic Stem CellsZIAHL006031 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI ZHAO, KEJI · 2009 to 2025
$16.6M
GENETICS TRAINING PROGRAM FOR PHD CANDIDATEST32GM007790 · NIGMS · STANFORD UNIVERSITY · PI BRUNET, ANNE, KINGSLEY, DAVID M · 1985 to 2020
$12.8M
ATP-Dependent Chromatin Remodeling in Human MalignancyR01CA163915 · NCI · STANFORD UNIVERSITY · PI Gerald R. Crabtree · 2012 to 2026
$5.4M
Signaling by Calcineurin and NFAT in Axonal OutgrowthR01NS046789 · NINDS · STANFORD UNIVERSITY · PI CRABTREE, GERALD R. · 2003 to 2012
$3.4M
ATP-Dependent Chromatin Regulation in Neurodevelopment and Human DiseaseR37NS046789 · NINDS · STANFORD UNIVERSITY · PI CRABTREE, GERALD R. · 2013 to 2019
$2.7M
Reversing Oncogenic BAF Complex Structure & Function: New Therapeutic ApproachesDP2CA195762 · NCI · DANA-FARBER CANCER INST · PI KADOCH, CIGALL · 2014 to 2014
$2.6M
Targeting Ovarian Cancer via Cooperative Oncogene InteractionsK99CA184043 · NCI · STANFORD UNIVERSITY · PI HARGREAVES, DIANA CLARE · 2014 to 2015
$342k
Dynamic effects of cancer mutations on the mammalian SWI/SNF ATPase BrgK99CA187565 · NCI · STANFORD UNIVERSITY · PI HODGES, HAMILTON COURTNEY · 2014 to 2015
$341k
Howard Hughes Medical InstituteNCI NIH HHS DP2 CA195762NCI NIH HHS K99 CA184043NCI NIH HHS K99 CA187565NCI NIH HHS P30 CA124435NCI NIH HHS R01 CA163915NHGRI NIH HHS T32 HG000044NIGMS NIH HHS T32 GM007790NINDS NIH HHS R01 NS046789NINDS NIH HHS R37 NS046789
6 · The paper itself

Abstract

The resolution and formation of facultative heterochromatin are essential for development, reprogramming, and oncogenesis. The mechanisms underlying these changes are poorly understood owing to the difficulty of studying heterochromatin dynamics and structure in vivo. We devised an in vivo approach to investigate these mechanisms and found that topoisomerase II (TOP2), but not TOP1, synergizes with BAF (mSWI/SNF) ATP-dependent chromatin remodeling complexes genome-wide to resolve facultative heterochromatin to accessible chromatin independent of transcription. This indicates that changes in DNA topology that take place through (de-)catenation rather than the release of torsional stress through swiveling are necessary for heterochromatin resolution. TOP2 and BAF cooperate to recruit pluripotency factors, which explains some of the instructive roles of BAF complexes. Unexpectedly, we found that TOP2 also plays a role in the re-formation of facultative heterochromatin; this finding suggests that facultative heterochromatin and accessible chromatin exist at different states of catenation or other topologies, which might be critical to their structures.

Indexed as

Chromatin Assembly and DisassemblyAnimalsChromatin ImmunoprecipitationDNADNA Topoisomerases, Type IIElectrophoresis, Agar GelEmbryonic Stem CellsEnhancer Elements, GeneticFibroblastsGenetic LociHeterochromatinMiceProtein BindingSirolimusTime FactorsTranscription, GeneticDNADNA Topoisomerases, Type IIHeterochromatinSirolimus

Identifiers

PMID28250416
PMCPMC5395302
OpenAlexW2594539676

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.